Straumann Holding AG (XSWX:STMN) EPS (Diluted) : CHF1.54 (TTM As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Straumann Holding AG EPS (Diluted)?

Straumann Holding AG's Earnings per Share (Diluted) for the six months ended in Dec. 2023 was CHF0.25. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was CHF1.54.

Straumann Holding AG's EPS (Basic) for the six months ended in Dec. 2023 was CHF0.25. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was CHF1.54.

Straumann Holding AG's EPS without NRI for the six months ended in Dec. 2023 was CHF1.33. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was CHF2.76.

During the past 12 months, Straumann Holding AG's average EPS without NRIGrowth Rate was -8.60% per year. During the past 3 years, the average EPS without NRIGrowth Rate was 19.50% per year. During the past 5 years, the average EPS without NRI Growth Rate was 11.30% per year. During the past 10 years, the average EPS without NRI Growth Rate was 16.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Straumann Holding AG's highest 3-Year average EPS without NRI Growth Rate was 109.80% per year. The lowest was -60.10% per year. And the median was 19.50% per year.

Straumann Holding AG EPS (Diluted) Historical Data

The historical data trend for Straumann Holding AG's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Straumann Holding AG EPS (Diluted) Chart

Straumann Holding AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Diluted)

Get a 7-Day Free Trial

1.93

0.57

2.48

2.72

1.54

Straumann Holding AG Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EPS (Diluted)	Get a 7-Day Free Trial															1.40	1.66	1.06	1.29	0.25

Competitive Comparison of Straumann Holding AG's EPS (Diluted)

For the Medical Instruments & Supplies subindustry, Straumann Holding AG's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Straumann Holding AG's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Straumann Holding AG's PE Ratio distribution charts can be found below:

* The bar in red indicates where Straumann Holding AG's PE Ratio falls into.

Straumann Holding AG EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Straumann Holding AG's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(246.072	-	0)	/	159.603
	=	1.54

Straumann Holding AG's Diluted EPS for the quarter that ended in Dec. 2023 is calculated as

Diluted EPS (Q: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(40.296	-	0)	/	159.579
	=	0.25

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF1.54

Straumann Holding AG (XSWX:STMN) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Straumann Holding AG EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Straumann Holding AG's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.

Straumann Holding AG (XSWX:STMN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Straumann Holding AG (XSWX:STMN) » Definitions » EPS (Diluted)

Comparable Companies

Traded in Other Exchanges

SAUHY:USA SAUHF:USA STMNz:UK 0QMV:UK

Address

Peter Merian-Weg 12, Basel, CHE, 4002

Website

https://www.straumann-group.com

Straumann is a global leader in tooth replacement and orthodontics solutions. Its line of products includes dental implants, abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. The company's core products are dental implants, and it holds roughly 30% of the global implant dentistry market, which is estimated to be worth roughly CHF 5.4 billion. Originally a pure premium implant player, Straumann entered the value market in 2012 with its acquisition of Neodent. Straumann now accounts for almost half of the global premium market and around 15% of the value market. While its premium product catalog is marketed under Straumann, its value brands include Neodent, Anthogyr, and Medentika as well as other local and regional brands.

Straumann Holding AG (XSWX:STMN) Headlines

No Headlines